Physician profile
Brian Shafer
NPI 1316131998
$12,981.07
in general payments reported to CMS, 2019-2025
64 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 93% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,923 · 2020: $1,635 · 2021: $2,834 · 2022: $1,844 · 2023: $1,669 · 2024: $1,480 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,745.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,723.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,317.70 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Pfizer INC. | $1,201.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,122.76 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $747.89 | 2019-2025 | Breztri, Airsupra |
| Astellas Pharma US INC | $538.03 | 2019-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $495.68 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $489.49 | 2019-2025 | Xifaxan |
| Amgen INC. | $464.84 | 2019-2024 | Repatha, Otezla, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $392.82 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $365.64 | 2019-2022 | |
| Esperion Therapeutics, INC. | $341.42 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $340.10 | 2019-2025 | Jardiance, Synjardy |
| Allergan, INC. | $269.74 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $232.83 | 2019-2022 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $207.53 | 2019-2025 | Eliquis, Camzyos |
| Axsome Therapeutics, INC. | $206.27 | 2023-2025 | Auvelity, Symbravo |
| Lundbeck LLC | $198.03 | 2021-2025 | Vyepti, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $195.46 | 2020-2024 | Trintellix |
| Amarin Pharma, INC. | $193.84 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $185.59 | 2021-2025 | Gvoke Hypopen |
| Lilly USA, LLC | $179.75 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceuticals, INC. | $169.10 | 2020-2021 | |
| Dexcom, INC. | $158.23 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $72.72 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $70.96 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $69.07 | 2023 | Rexulti |
| Neurelis, INC. | $58.15 | 2023 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $54.29 | 2020-2021 | |
| Inogen, INC. | $53.62 | 2022-2023 | Inogen At Home Stationary Concentrator |
| Intuitive Surgical, INC. | $51.71 | 2025 | |
| Philips North America LLC | $47.91 | 2019-2024 | (Ck7) Extended Holter |
| Merck Sharp & Dohme LLC | $43.94 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Daiichi Sankyo INC. | $41.92 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $41.52 | 2020-2022 | |
| Linvatec Corporation | $40.30 | 2023-2024 | Biobrace 23mm, Allograft Tissue |
| Medtronic, INC. | $38.76 | 2023-2025 | Intellis Adaptivestim |
| Abbott Laboratories | $36.45 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $32.23 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $29.45 | 2019-2024 | Strensiq |
| Horizon Therapeutics Plc | $28.95 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $28.48 | 2019 | |
| Vanda Pharmaceuticals INC. | $27.37 | 2021-2022 | |
| Eisai INC. | $26.65 | 2020 | |
| Almatica Pharma LLC | $26.06 | 2021 | |
| Convatec INC. | $25.41 | 2021 | |
| Pacira Therapeutics, INC. | $25.20 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $24.02 | 2025 | |
| Corcept Therapeutics | $23.56 | 2019 | |
| Corium, LLC | $21.98 | 2023 | Adlarity |
| Tactile Systems Technology INC | $19.72 | 2023 | Flexitouch Plus, Entre Plus |
| Inspire Medical Systems, INC. | $19.53 | 2025 | Inspire |
| Smith+Nephew, INC. | $17.94 | 2019 | |
| Dynavax Technologies Corporation | $17.05 | 2025 | Heplisav-B |
| Kinex Medical Company LLC | $16.84 | 2020 | |
| Bioventus LLC | $16.48 | 2022 | |
| Duchesnay USA Incorporated | $14.28 | 2019 | |
| Valeritas, INC. | $14.09 | 2019 | |
| Exact Sciences Corporation | $13.71 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $12.37 | 2019 | |
| Lifescan, INC. | $12.32 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.30 | 2021 | |
| Medela LLC | $9.33 | 2022 | |
| Phathom Pharmaceuticals, INC. | $6.24 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shafer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.